Bryan A. Galvez

FDA investigator

Appears on 15 documents from 2018 to 2026, mostly at sites in California. Most often cites production record review (21 CFR 211.192).

15
Documents on file
3.9
Observations per 483
2018
First seen
2026
Most recent

What they cite most

From 59 observations

Activity by year

2018: 2, 2019: 3, 2021: 3, 2022: 2, 2023: 3, 2024: 1, 2026: 1

Where

California 13 · South Korea 1 · Taiwan 1

Is Bryan A. Galvez coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

15 documents, newest first
FirmOpen
Amended 483 Pyramid Laboratories, IncFeb 13, 2026 · Costa Mesa, California
483 Bioduro LLCFeb 23, 2024 · Irvine, California
483 Clinical Resolution Laboratory, Inc.Sep 29, 2023 · Brea, California
483 Teh Seng Pharmaceutical Mfg. Co., Ltd.Aug 4, 2023 · Tainan City, Taiwan
483 Tanvex BioPharma USA, IncJan 24, 2023 · San Diego, California
483 Auro Pharmacies, Inc.Aug 12, 2022 · La Habra, California
483 Kolmar Korea Co., LtdJul 7, 2022 · Sejong-Si, South Korea

About this profile

What does Bryan A. Galvez inspect?

Bryan A. Galvez appears on 15 documents on file covering 15 sites, mostly in California.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.165 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Bryan A. Galvez is dated Feb 13, 2026.

FDA Investigator Bryan A. Galvez: 483s & Inspections · FDA Intel